Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 32758 | 103 | 24.1 | 34% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 2431 | 3649 | MOYAMOYA DISEASE//MOYAMOYA//MOYAMOYA SYNDROME |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | SOLCOSERYLR | Author keyword | 3 | 100% | 3% | 3 |
| 2 | WOUND HEALING DRUGS | Author keyword | 3 | 100% | 3% | 3 |
| 3 | ACTOVEGIN | Author keyword | 3 | 33% | 7% | 7 |
| 4 | HEMODIALYSATE | Author keyword | 1 | 38% | 3% | 3 |
| 5 | HAEMODIALYSATE | Author keyword | 1 | 100% | 2% | 2 |
| 6 | HEMODIALYSATE PROTEIN FREE | Author keyword | 1 | 100% | 2% | 2 |
| 7 | SOLCOSERYL | Author keyword | 1 | 30% | 3% | 3 |
| 8 | ANTIOXIDATIVE STATE | Author keyword | 1 | 50% | 1% | 1 |
| 9 | ENCEPHALOTROPIC DRUGS | Author keyword | 1 | 50% | 1% | 1 |
| 10 | MED WISSEN | Address | 0 | 33% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | SOLCOSERYLR | 3 | 100% | 3% | 3 | Search SOLCOSERYLR | Search SOLCOSERYLR |
| 2 | WOUND HEALING DRUGS | 3 | 100% | 3% | 3 | Search WOUND+HEALING+DRUGS | Search WOUND+HEALING+DRUGS |
| 3 | ACTOVEGIN | 3 | 33% | 7% | 7 | Search ACTOVEGIN | Search ACTOVEGIN |
| 4 | HEMODIALYSATE | 1 | 38% | 3% | 3 | Search HEMODIALYSATE | Search HEMODIALYSATE |
| 5 | HAEMODIALYSATE | 1 | 100% | 2% | 2 | Search HAEMODIALYSATE | Search HAEMODIALYSATE |
| 6 | HEMODIALYSATE PROTEIN FREE | 1 | 100% | 2% | 2 | Search HEMODIALYSATE++PROTEIN+FREE | Search HEMODIALYSATE++PROTEIN+FREE |
| 7 | SOLCOSERYL | 1 | 30% | 3% | 3 | Search SOLCOSERYL | Search SOLCOSERYL |
| 8 | ANTIOXIDATIVE STATE | 1 | 50% | 1% | 1 | Search ANTIOXIDATIVE+STATE | Search ANTIOXIDATIVE+STATE |
| 9 | ENCEPHALOTROPIC DRUGS | 1 | 50% | 1% | 1 | Search ENCEPHALOTROPIC+DRUGS | Search ENCEPHALOTROPIC+DRUGS |
| 10 | EEG BRAIN MAPPING | 0 | 14% | 2% | 2 | Search EEG+BRAIN+MAPPING | Search EEG+BRAIN+MAPPING |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PROTEIN FREE HAEMODIALYSATE | 6 | 100% | 4% | 4 |
| 2 | INOSITOL PHOSPHATE OLIGOSACCHARIDES | 3 | 50% | 5% | 5 |
| 3 | BLOOD EXTRACT | 3 | 60% | 3% | 3 |
| 4 | SOLCOSERYL | 2 | 50% | 3% | 3 |
| 5 | FREE HAEMODIALYSATE | 1 | 100% | 2% | 2 |
| 6 | HEMODIALYSATE | 0 | 33% | 1% | 1 |
| 7 | DIRTY BOMB | 0 | 20% | 1% | 1 |
| 8 | ACTOVEGIN | 0 | 100% | 1% | 1 |
| 9 | BLOOD DIALYSATE | 0 | 100% | 1% | 1 |
| 10 | FREE BLOOD EXTRACT | 0 | 100% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Our Experience on Actovegin, is it Cutting Edge? | 2011 | 10 | 18 | 28% |
| Solcoseryl in the therapy of cerebrovascular pathology (literature review) | 2007 | 0 | 5 | 60% |
| OXYGEN-TRANSPORT IN PERIPHERAL VASCULAR-DISEASE - A NOVEL-APPROACH TO THE SEARCH FOR EFFECTIVE AGENTS | 1991 | 0 | 18 | 6% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MED WISSEN | 0 | 33% | 1.0% | 1 |
| 2 | CLIN ANAESTHESIOL INTENS MED | 0 | 25% | 1.0% | 1 |
| 3 | ANESTHESIOL USCITAT TRANSFUSIOL | 0 | 100% | 1.0% | 1 |
| 4 | KLIN NEUROCHIRURG REHABIL HATTINGEN HOLTHAUSEN | 0 | 100% | 1.0% | 1 |
| 5 | MED PHARMACEUT BIOTECHNOL IMC KREMS | 0 | 100% | 1.0% | 1 |
| 6 | MOSCOW CITY HOSP 8 | 0 | 100% | 1.0% | 1 |
| 7 | ONTARIO CANC NUCL MED | 0 | 100% | 1.0% | 1 |
| 8 | PREVENT TREATMENT DIABET MELLITUS | 0 | 100% | 1.0% | 1 |
| 9 | UKRAINIAN PRACT ENDOCRINAL SURG TRANS | 0 | 100% | 1.0% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000195784 | OMENTAL TRANSPOSITION//OMENTUM TRANSPOSITION//BRIDGING FLAP |
| 2 | 0.0000141525 | MONOCYTE MATURATION//PEPTIDE FRACTION//TUMORCYTOTOXICITY |
| 3 | 0.0000130437 | CONGREGATE NUTRITION SITE//NEUROLEPTIC SIDE EFFECTS//PRAZOSIN HYDROCHLORIDE |
| 4 | 0.0000112977 | OPHTHALMIC EMULSION//LACRIMAL FUNCTION//EXPTL PATHOL DIFFERENTIAT CONTROL SECT |
| 5 | 0.0000089568 | BUREAU BARRIERE SYNDROME//RETROGRADE VENOUS PERFUSION//FB RATIO |
| 6 | 0.0000081867 | EXUBERANT GRANULATION TISSUE//WOUND HEALING RECONSTRUCT SURG PROGRAM//AXIAL PATTERN FLAP |
| 7 | 0.0000070636 | TETRATHIOMOLYBDATE//ATN 224//ANGIOTROPIN CURNP RIBOKINE |
| 8 | 0.0000069825 | AROTINOLOL//SHICHIMOTSU KOKA TO//SHICHIMOTSUKOKATO |
| 9 | 0.0000068482 | ACUTE REJECTION REACTION//TUMOR ANGIOGENESIS//E S 8 |
| 10 | 0.0000067367 | FOLLICULAR DYSPLASIA//COLOUR DILUTION ALOPECIA//HAIRLESS DOGS |